Clinical Trial Update: An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended Release (ER) in Participants With Schizophrenia [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the efficacy, safety and tolerability of flexibly dosed paliperidone extended release (ER) in participants with schizophrenia has bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Paliperidone ER (paliperidone)

Snippet

Sponsor: Janssen-Cilag International NV | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED